[go: up one dir, main page]

EA200870236A1 - Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе - Google Patents

Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе

Info

Publication number
EA200870236A1
EA200870236A1 EA200870236A EA200870236A EA200870236A1 EA 200870236 A1 EA200870236 A1 EA 200870236A1 EA 200870236 A EA200870236 A EA 200870236A EA 200870236 A EA200870236 A EA 200870236A EA 200870236 A1 EA200870236 A1 EA 200870236A1
Authority
EA
Eurasian Patent Office
Prior art keywords
monohydrate
rhimnabant
basis
production
pharmaceutical compositions
Prior art date
Application number
EA200870236A
Other languages
English (en)
Inventor
Жерар Кокерель
Элен Дюпла
Батист Фур
Оливье Моннье
Филипп Оксенбен
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37075667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200870236(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA200870236A1 publication Critical patent/EA200870236A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к моногидрату римонабанта, к способу его получения и к содержащей его фармацевтической композиции.
EA200870236A 2006-02-08 2007-02-05 Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе EA200870236A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601253A FR2897060B1 (fr) 2006-02-08 2006-02-08 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
PCT/FR2007/000201 WO2007090949A1 (fr) 2006-02-08 2007-02-05 Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Publications (1)

Publication Number Publication Date
EA200870236A1 true EA200870236A1 (ru) 2009-02-27

Family

ID=37075667

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870236A EA200870236A1 (ru) 2006-02-08 2007-02-05 Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе

Country Status (20)

Country Link
US (1) US20090048449A1 (ru)
EP (1) EP1984341A1 (ru)
JP (1) JP2009526025A (ru)
KR (1) KR20080093042A (ru)
CN (1) CN101405271A (ru)
AR (1) AR059327A1 (ru)
AU (1) AU2007213649A1 (ru)
BR (1) BRPI0707711A2 (ru)
CA (1) CA2641494A1 (ru)
DO (1) DOP2007000023A (ru)
EA (1) EA200870236A1 (ru)
FR (1) FR2897060B1 (ru)
GT (1) GT200700014A (ru)
IL (1) IL192963A0 (ru)
MA (1) MA30312B1 (ru)
NO (1) NO20083521L (ru)
TW (1) TW200804343A (ru)
UY (1) UY30137A1 (ru)
WO (1) WO2007090949A1 (ru)
ZA (1) ZA200806713B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057144A4 (en) * 2006-09-01 2010-06-02 Hetero Drugs Ltd NEW POLYMORPHIC FROM RIMONABANT
WO2008056377A2 (en) * 2006-11-06 2008-05-15 Cadila Healthcare Limited Polymorphic forms of rimonabant
HUE043014T2 (hu) * 2014-12-08 2019-07-29 Crystal Pharmatech Co Ltd Valzartánt és AHU 377-et tartalmazó trinátrium szupramolekuláris komplex kristályos formái, és az ezekhez tartozó eljárások

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2831883B1 (fr) * 2001-11-08 2004-07-23 Sanofi Synthelabo Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
JP4746931B2 (ja) * 2005-07-22 2011-08-10 株式会社日立製作所 フラットディスプレイパネルモジュール及びフラットディスプレイ装置
EP2057144A4 (en) * 2006-09-01 2010-06-02 Hetero Drugs Ltd NEW POLYMORPHIC FROM RIMONABANT
WO2008035023A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Polymorphs of rimonabant

Also Published As

Publication number Publication date
ZA200806713B (en) 2009-10-28
IL192963A0 (en) 2009-02-11
KR20080093042A (ko) 2008-10-17
CA2641494A1 (fr) 2007-08-16
AR059327A1 (es) 2008-03-26
DOP2007000023A (es) 2008-02-15
FR2897060B1 (fr) 2008-07-25
FR2897060A1 (fr) 2007-08-10
WO2007090949A1 (fr) 2007-08-16
MA30312B1 (fr) 2009-04-01
TW200804343A (en) 2008-01-16
BRPI0707711A2 (pt) 2011-05-10
JP2009526025A (ja) 2009-07-16
AU2007213649A1 (en) 2007-08-16
UY30137A1 (es) 2007-09-28
GT200700014A (es) 2007-09-19
US20090048449A1 (en) 2009-02-19
EP1984341A1 (fr) 2008-10-29
NO20083521L (no) 2008-10-24
CN101405271A (zh) 2009-04-08

Similar Documents

Publication Publication Date Title
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201070786A1 (ru) Бензофуропиримидиноны
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
EA200970580A1 (ru) Таннат разагилина
AU2009301431A8 (en) Bispecific anti-VEGF/anti-ANG-2 antibodies
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
MX2009000884A (es) Derivados de piridizinona.
EA200802008A1 (ru) Фармацевтические композиции
DK2068822T3 (da) Selvpræserverede vandige farmaceutiske sammensætninger
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
WO2008021849A3 (en) Novel compounds as antagonists or inverse agonists at opioid receptors
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
BRPI0607645A2 (pt) sais de derivados de hexaidrofenantridina substituìdos com 6-heterociclila
EA201001353A1 (ru) Гидробромид ивабрадина
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе